Retinopathy of prematurity: risk factors in a prospective population-based study
- PMID: 1553319
- DOI: 10.1111/j.1365-3016.1992.tb00747.x
Retinopathy of prematurity: risk factors in a prospective population-based study
Abstract
A prospective study of risk factors for retinopathy of prematurity (ROP) in all very low birthweight (less than 1500 g) infants born in New Zealand in 1986 is reported. Of 413 liveborn infants admitted to neonatal units, 338 (81.2%) survived to be discharged home. Of surviving infants, 313 (93%) were examined by indirect ophthalmoscopy, as were eight infants who died before discharge. Sixty-nine infants (21.5% of 321) had acute retinopathy. On multiple logistic regression analysis, three variables made statistically significant independent contributions to the risk of any acute retinopathy; gestational age (P less than 0.0001), principal hospital caring for the infant (P less than 0.01) and treatment with indomethacin (P less than 0.01). Only two variables, gestational age (P less than 0.0001) and hospital (P less than 0.01), made significant contributions to the risk of stage 2 or more ROP. For both categories of ROP, timing of the examination also had a statistically significant effect (P less than 0.001). After adjustment for other significant predictor variables, it was estimated that approximately 70% of infants of less than 26 weeks' gestation were at risk of ROP and nearly 50% of stage 2 or more ROP, in comparison with less than 2% of infants of 32 weeks' gestation or more; infants treated with indomethacin were over 1.5 times more likely to have ROP than infants not so treated. Failure to enforce uniform timing of examination was the most serious defect in the study; only 205 (64%) of the 321 infants were examined at the recommended time. However, reanalysis of the model with information limited to these 205 infants yielded similar risk factors. The incidence of ROP, both observed (P less than 0.05) and adjusted for other significant variables in the regression model (P less than 0.01) was lowest in the two largest level III hospitals. These hospitals also had the best survival rates after adjustment for birthweight, gestation and gender (P less than 0.01). We speculate that the larger level III units obtained better results because their size and experience enabled them to provide a better overall quality of care.
Similar articles
-
Retinopathy of prematurity in infants < 32 weeks' gestation at birth in New South Wales in 1993 and 1994.J Paediatr Child Health. 1999 Aug;35(4):355-7. J Paediatr Child Health. 1999. PMID: 10457291
-
Incidence of retinopathy of prematurity requiring treatment in infants born greater than 30 weeks' gestation and with a birthweight greater than 1250 g from 1998 to 2002: a regional study.J Paediatr Child Health. 2006 Jun;42(6):337-40. doi: 10.1111/j.1440-1754.2006.00868.x. J Paediatr Child Health. 2006. PMID: 16737473
-
Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network.Pediatrics. 2005 Apr;115(4):990-6. doi: 10.1542/peds.2004-1309. Pediatrics. 2005. PMID: 15805375
-
Incidence of retinopathy of prematurity in infants born before 27 weeks' gestation in Sweden.Arch Ophthalmol. 2009 Oct;127(10):1315-9. doi: 10.1001/archophthalmol.2009.244. Arch Ophthalmol. 2009. PMID: 19822848
-
Effect of mode of delivery on incidence of retinopathy of prematurity: a systematic review and meta-analysis.BMJ Open Ophthalmol. 2024 Jun 25;9(1):e001678. doi: 10.1136/bmjophth-2024-001678. BMJ Open Ophthalmol. 2024. PMID: 38918018 Free PMC article.
Cited by
-
Breast milk feeding and cognitive ability at 7-8 years.Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F23-7. doi: 10.1136/fn.84.1.f23. Arch Dis Child Fetal Neonatal Ed. 2001. PMID: 11124919 Free PMC article.
-
Outcomes of near confluent laser versus combined less dense laser and bevacizumab treatment of prethreshold ROP Type 1 Zone 2: a randomized controlled trial.BMC Ophthalmol. 2022 Nov 28;22(1):454. doi: 10.1186/s12886-022-02689-0. BMC Ophthalmol. 2022. PMID: 36443750 Free PMC article. Clinical Trial.
-
Retinopathy of prematurity: a review of risk factors and their clinical significance.Surv Ophthalmol. 2018 Sep-Oct;63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19. Surv Ophthalmol. 2018. PMID: 29679617 Free PMC article. Review.
-
Capacity building of nurses providing neonatal care in Rio de Janeiro, Brazil: methods for the POINTS of care project to enhance nursing education and reduce adverse neonatal outcomes.BMC Nurs. 2012 Mar 12;11:3. doi: 10.1186/1472-6955-11-3. BMC Nurs. 2012. PMID: 22409747 Free PMC article.
-
Adopting Western Retinopathy of Prematurity Screening Programs in Eastern Countries, are we Screening Properly?Middle East Afr J Ophthalmol. 2011 Jul;18(3):209-13. doi: 10.4103/0974-9233.84047. Middle East Afr J Ophthalmol. 2011. PMID: 21887075 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources